Immunoglobulin M (IgM)-Anti-myelin-associated-glycoprotein(MAG) Peripheral Neuropathy Study

RecruitingOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

June 23, 2020

Primary Completion Date

June 23, 2030

Study Completion Date

June 23, 2030

Conditions
Immunoglobin M Anti-myelin-associated-glycoprotein Peripheral Neuropathy
Interventions
OTHER

Clinical examination and patients' questionnaires regarding activity and participation (preliminary Immunogloblin M (IgM)-Rasch-built overall Disability Scale (RODS), and finalized IgM-RODS)

Rasch-built overall Disability Scale (RODS) is a disease-specific, patient-based, linearly weighted scale that captures activity and social participation limitations to detect activity limitations in patients with Immunogloblin M (IgM) anti-myelin-associated-glycoprotein peripheral neuropathy. For this study, the preliminary RODS is a 146 item patient-reported outcome instrument that assesses activity and social participation limitation. Rasch Measurement Methods examine the extent observed data (patients' actual responses to scale items) accord with predictions of those responses from a mathematical model.

Trial Locations (2)

69500

RECRUITING

Hospices Civils de Lyon Service Neurologie C, Pathologies Neuromusculaires, Unité 302, Bron

94275

RECRUITING

Centre de référence NNERf, Le Kremlin-Bicêtre

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER